Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Please keep all scheduled appointments with your doctor and the laboratory on ti···【more】
Release date：2026-01-16Recommended：253
Pralsetinib may interfere with the efficacy of hormonal contraceptives (includin···【more】
Release date：2026-01-16Recommended：272
Although severe adverse reactions to Pralsetinib (brand name: Gavreto) are relat···【more】
Release date：2026-01-16Recommended：233
Pralsetinib is indicated for the treatment of adult patients with specific types···【more】
Release date：2026-01-16Recommended：245
The efficacy of Pralsetinib was investigated in a multicenter, open-label, multi···【more】
Release date：2026-01-16Recommended：223
Pralsetinib is the sixth drug under Genentech that has obtained FDA approval for···【more】
Release date：2026-01-16Recommended：273
Please take pralsetinib strictly in accordance with the instructions of medical ···【more】
Release date：2026-01-16Recommended：217
Pralsetinib, also known as GAVRETO, is a targeted therapy medication administere···【more】
Release date：2026-01-16Recommended：260
Pralsetinib is a tyrosine kinase inhibitor administered via oral route.Which Pat···【more】
Release date：2026-01-16Recommended：213
Trabectedin (Yondelis) is a prescription medication indicated for the treatment ···【more】
Release date：2026-01-16Recommended：207
On December 1, 2020, South San Francisco, California – Genentech, a member of th···【more】
Release date：2026-01-15Recommended：231
On August 9, 2023, the U.S. Food and Drug Administration (FDA) approved pralseti···【more】
Release date：2026-01-15Recommended：205
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
